SEER Earnings Date: Nov 10, 2026 (Estimated) — Seer, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is SEER's next earnings date?
Seer, Inc. (SEER) is expected to report Q3 2026 earnings on Tuesday, November 10, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.26 on revenue of $4.2M.
How did SEER do in its last earnings report?
In its most recent report on Aug 11, 2026 (Q2 2026), Seer, Inc. posted EPS of -$0.31 versus the -$0.27 estimate, a miss of 24.0%. Revenue was $3.1M against a $3.5M estimate. The stock's 1-day post-earnings move was -0.9%.
How much does SEER stock move after earnings?
SEER beat EPS estimates in 3 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 5.6% (up or down) in the day after earnings.
About Seer, Inc.
Seer, Inc. is a life sciences firm specializing in developing and commercializing advanced technologies designed to unravel the complexities of the proteome. At the core of its offerings is the Proteograph Product Suite, an integrated platform comprising specialized consumables, automated instrumentation, and sophisticated software. This comprehensive solution empowers researchers to conduct advanced proteomic studies across various applications, including therapeutic and diagnostic investigations, as well as clinical trials. The company markets its products exclusively for research applications, serving academic institutions, diverse life sciences and research laboratories, and biopharmaceutical and biotechnology enterprises. Notably, these offerings are intended for non-diagnostic and non-clinical purposes. Seer has established collaborative agreements with entities such as Discovery Life Sciences, LLC, and the Salk Institute for Biological Studies. Originally incorporated in 2017 as Seer Biosciences, Inc., the company adopted its current name, Seer, Inc., in July 2018. Its headquarters are situated in Redwood City, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-11 | Q2 2026 | -0.27 | -0.31 | -24.00% | $3.1M | ❌ Miss | -0.93% | -6.48% | -10.65% |
| 2026-05-13 | Q1 2026 | -0.27 | -0.30 | -11.11% | $2.8M | ❌ Miss | -1.13% | -5.08% | -2.82% |
| 2026-02-26 | Q4 2025 | -0.34 | -0.29 | +14.71% | $4.2M | ✅ Beat | -17.31% | -11.54% | -20.19% |
| 2025-11-06 | Q3 2025 | -0.31 | -0.32 | -3.23% | $4.1M | ❌ Miss | -3.24% | -5.56% | -14.35% |
| 2025-08-06 | Q2 2025 | -0.38 | -0.33 | +13.16% | $4.1M | ✅ Beat | -2.43% | +5.34% | +1.94% |
| 2025-02-27 | Q4 2024 | -0.39 | -0.37 | +5.13% | $4.0M | ✅ Beat | -4.55% | -9.09% | -20.91% |
| 2024-11-06 | Q3 2024 | -0.31 | -0.35 | -12.90% | $4.0M | ❌ Miss | +7.25% | +11.59% | +19.81% |
| 2024-05-08 | Q1 2024 | -0.32 | -0.32 | +0.00% | $3.1M | ➖ Inline | -7.62% | -4.04% | -22.42% |
Showing last 8 quarters.